Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced ...
*These authors contributed equally to the preparation of this manuscript. Cell-based technologies for printing protein microarrays are faced with poor protein expression, protein insolubility, ...
Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...
Abstract: Microarray chip technology has met the challenges of traditional fluorescent labeling in terms of high cost and low detection efficiency , and provides a high-throughput and cost-effective ...
Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...
Dr. Min-young Lee and Dr. Sung-gyu Park of the Advanced Bio and Healthcare Materials Research Division at KIMS have developed a technology that can detect cancer mutant genes in blood with the world's ...
The molecular diagnostics market size reached a value of $15.42 billion in 2023 and is expected to rise to $25.27 billion by 2032, growing at a CAGR of 5.3% for the forecast period from 2024 to 2032.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback